Warning
This is an unofficial archive of PsychonautWiki as of 2025-08-08T03:33:20Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.

Template:DangerousInteractions/SerotoninSyndrome: Difference between revisions

From PsychonautWiki Archive
Jump to navigation Jump to search
>Rhz
added back dangerous interaction annotation for serotonin releasers
>Oskykins
No edit summary
Line 3: Line 3:
*'''[[DangerousInteraction::Serotonin releasers]]''' such as '''[[MDMA]]''', '''[[4-FA]]''', '''[[MDAI]]''' and '''[[αMT]]'''
*'''[[DangerousInteraction::Serotonin releasers]]''' such as '''[[MDMA]]''', '''[[4-FA]]''', '''[[MDAI]]''' and '''[[αMT]]'''
*'''[[DangerousInteraction::Selective serotonin re-uptake inhibitors]] (SSRIs)'''
*'''[[DangerousInteraction::Selective serotonin re-uptake inhibitors]] (SSRIs)'''
*'''[[DangerousInteraction::Serotonin-norepinephrine reuptake inhibitors]] (SNRIs)'''
*'''[[DangerousInteraction::5-HTP]]'''
*'''[[DangerousInteraction::5-HTP]]'''

Revision as of 00:54, 30 October 2016

Combinations in the list below may increase the amount of neurotransmitters such as serotonin and dopamine to dangerous or even fatal levels.

  1. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity | http://bja.oxfordjournals.org/content/95/4/434